TAK-411

Biologic (subtype unspecified)

Mechanism not established

Automated registry profile: compiled from public clinical-trial and regulatory records; not yet individually analyst-verified.

—no market stage

Evidence outlook

Studies registered, no market-specific stage

Studies of this drug are registered, but none is matched to a market this site covers, so no stage is set and there is nothing to grade. The registry list shows each study.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 2 (1)
Other / comorbidity
NCT06798012 · Takeda
2025-05-14 – 2028-06-08 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
What this study did

Competitive landscape

This drug's own stage for Chronic Inflammatory Demyelinating Polyneuropathy: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
TAK-411: this drugStage not on recordBiologic (subtype unspecified)—not yet gradedNo reviewed efficacy summary in this indication
Efgartigimod Alfa (Vyvgart)
Approved(overall)
Antibody fragmentFcRnnot yet gradedNo reviewed efficacy summary in this indication
Efgartigimod Alfa And Hyaluronidase (Vyvgart Hytrulo)ApprovedAntibody fragmentFcRnnot yet gradedNo reviewed efficacy summary in this indication
RiliprubartPhase 3Monoclonal antibodyComplement C1snot yet gradedNo reviewed efficacy summary in this indication
ImeroprubartPhase 2Monoclonal antibodyFcRnnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow TAK-411 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
December 2027 (1)
Phase 2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Recruiting
Est. primary completion 2027-12-02 · NCT06798012 · CT.gov ↗
What to watch

See the full readout calendar ↗